Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignancy markers in the cerebrospinal fluid.

M Koskiniemi1

  • 1Childrens' Hospital, Helsinki, Finland.

European Journal of Pediatrics
|October 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human parechovirus and the risk of type 1 diabetes.

Journal of medical virology·2013
Same author

Viral meningoencephalitis: a review of diagnostic methods and guidelines for management.

European journal of neurology·2010
Same author

HHV-6 infection in multiple sclerosis. A clinical and laboratory analysis.

European journal of neurology·2009
Same author

Confirmed primary HHV-6 infection in children with suspected encephalitis.

Neuropediatrics·2008
Same author

Evidence for human herpesvirus 6 variant A antibodies in multiple sclerosis: diagnostic and therapeutic implications.

Journal of neurovirology·2007
Same author

Viral encephalitis: a review of diagnostic methods and guidelines for management.

European journal of neurology·2005
Same journal

The anatomical type of atresia drives the risk of home parenteral nutrition of infants with congenital jejunoileal atresia.

European journal of pediatrics·2026
Same journal

Neurological outcomes in extremely preterm infants with periventricular hemorrhagic infarction: clinical and cranial ultrasound findings.

European journal of pediatrics·2026
Same journal

Disease severity of children with hereditary spherocytosis predicts the clinical course of aplastic crisis.

European journal of pediatrics·2026
Same journal

Long-term recurrence and acute seizure clustering in children with convulsions with mild gastroenteritis: a systematic review and meta-analysis.

European journal of pediatrics·2026
Same journal

Cost-benefit analysis of nirsevimab for respiratory syncytial virus prevention in infants: a population-based study.

European journal of pediatrics·2026
Same journal

Consensus statement on the use of standardized early mobilization in pediatric patients admitted to pediatric intensive care units in Italy.

European journal of pediatrics·2026
See all related articles

Detecting central nervous system malignancies in cerebrospinal fluid (CSF) requires sensitive markers. This study explores various biomarkers for early detection, therapy monitoring, and relapse identification in neurological cancers.

Area of Science:

  • Neuro-oncology
  • Biomarker Discovery
  • Cerebrospinal Fluid Analysis

Background:

  • Current malignancy markers in CSF often lack sufficient specificity and sensitivity.
  • Accurate detection is crucial for early diagnosis, therapy monitoring, and identifying relapses, even at subclinical stages.
  • High methodological standards are essential for reliable biomarker determination.

Purpose of the Study:

  • To review and evaluate various substances in CSF as potential indicators of central nervous system malignancies.
  • To discuss the diagnostic and prognostic significance of different biomarkers.
  • To highlight challenges and pitfalls in the determination of these markers.

Main Methods:

  • Literature review of existing studies on CSF biomarkers for CNS malignancies.

Related Experiment Videos

  • Analysis of the role of specific substances like human chorionic gonadotrophin, alpha-fetoprotein, desmosterol, putrescine, fibronectin, ferritin, and beta-2-microglobulin.
  • Discussion of the utility of tumor-specific antigens and growth factors.

    • Main Results:

    • Malignant cells in CSF are indicative of leptomeningeal involvement (metastases, leukemia), but rare in primary brain tumors.
    • Human chorionic gonadotrophin and alpha-fetoprotein aid in detecting cerebral germ cell tumors and relapses.
    • Desmosterol, putrescine, fibronectin, ferritin, and beta-2-microglobulin show potential in diagnosing specific tumors (medulloblastomas, gliomas, ALL) and monitoring treatment.
    • Tumor-specific antigens and growth factors may offer greater significance than non-specific brain proteins.

    Conclusions:

    • Cerebrospinal fluid analysis offers several promising biomarkers for diagnosing and monitoring central nervous system malignancies.
    • The utility of markers varies, with some being more effective for specific tumor types or for tracking therapeutic response and relapses.
    • Further research and standardization of methods are needed to improve the clinical application of CSF-based malignancy markers.